SCHEMBL29636838

SCHEMBL29636838

CC(C)(C)OC(=O)N1Cc2cn(-c3ccc(-c4cc(Cl)c5ccccc5n4)cc3)nc2C1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMYD3 Q9H7B4 1/20 0.39
PDK2 Q15119 1/20 0.38
ACACB O00763 5/20 0.38
SLC6A9 P48067 4/20 0.38
SLC34A1 Q06495 1/20 0.38
ACACA Q13085 3/20 0.37
GPR119 Q8TDV5 2/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PIK3CA P42336 1/20 0.37
MTOR P42345 1/20 0.37
C5AR1 P21730 1/20 0.37
GRM5 P41594 1/20 0.36
GRM1 Q13255 1/20 0.36
GBA1 P04062 1/20 0.36
DHODH Q02127 1/20 0.36
KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23015253 1.00 SMYD3 (0.39) SMYD3PDK2ACACBSLC6A9SLC34A1
SCHEMBL28967182 0.87 HPGD (0.41) SMYD3PDK2SLC6A9HPGDSMN1; SMN2
SCHEMBL29636795 0.82 ACACB (0.41) ACACBACACA
SCHEMBL23015287 0.82 ACACB (0.41) ACACBACACA
SCHEMBL23015108 0.80 ALDH1A1 (0.53) SMYD3GPR119HPGDSMN1; SMN2GBA1
SCHEMBL29636833 0.80 ALDH1A1 (0.53) SMYD3GPR119HPGDSMN1; SMN2GBA1
SCHEMBL23015352 0.75 HDAC1 (0.45) PDK2SLC6A9SLC34A1GPR119GRM5
SCHEMBL17202429 0.75 GRM5 (0.49) PDK2SLC6A9SLC34A1GPR119GRM5
SCHEMBL26967660 0.74 ALDH1A1 (0.44) SLC34A1GPR119HPGDSMN1; SMN2PIK3CA
SCHEMBL28967185 0.73 PDK2 (0.42) PDK2SLC6A9SLC34A1GPR119GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4017492-A1 MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED DISORDERS Biohaven Therapeutics Ltd. (US) 2022-06-29 EP disclosed
CN-114667145-A Molecules that bind to TDP-43 for the treatment of amyotrophic lateral sclerosis and related disorders 拜尔哈文制药股份有限公司 2022-06-24 CN disclosed